The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients

15/06/2021
18/01/2022
EU PAS number:
EUPAS41519
Study
Ongoing
Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Medical condition to be studied

Chronic obstructive pulmonary disease
Population studied

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

91600
Study design details

Main study objective

To determine the prevalence of comorbid conditions in COPD patients in primary health care and to assess their association with exacerbation rate and COPD-related health status.

Outcomes

Exacerbations and COPD-related health status measured by the CAT, CCQ or mMRC.

Data analysis plan

Differences between groups (based on number of comorbid conditions) defined as number of exacerbations and COPD-related health status measured by CAT, CCQ or mMRC will be tested using methods such as factorial analysis of covariance (ANCOVA) adjusting for age, sex, FEV1 % of predicted and BMI. Logistic regression will be used for testing the number of comorbidities associated with higher scores of CCQ, CAT and mMRC.